|国家科技期刊平台
首页|期刊导航|安徽医科大学学报|低剂量地塞米松联合PB21对膝骨关节炎大鼠镇痛作用的影响

低剂量地塞米松联合PB21对膝骨关节炎大鼠镇痛作用的影响OA北大核心CSTPCD

Effect of low-dose dexamethasone combined with PB21 on analgesic effect in rats with knee osteoarthritis

中文摘要英文摘要

目的 研究低剂量地塞米松(Dex)联合布比卡因缓释剂(PB21)对膝骨关节炎(KOA)大鼠镇痛时间的影响及其机制.方法 以半月板失稳和前交叉韧带横断方法制备大鼠KOA模型,8周后将成模后的SD大鼠随机分为模型组、Dex 组(50 μg/只)、PB21 组(1.5 mg/只)、PB21+Dex 组[PB21(1.5mg/只)+Dex(50 μg/只)],另设假手术组为对照.使用PAM压力应用测量系统分别测量给药前和给药后4、24、36、48 h各时间点KOA大鼠的疼痛阈值;使用步态仪(CatWalk)检测大鼠给药前和给药后4、24、48 h足爪平均强度及最大接触面积;在给药后4、24、48 h分别处死部分大鼠,取关节滑膜制作石蜡切片,免疫组化检测滑膜中生长相关蛋白43(GAP43)的表达,免疫荧光检测降钙素基因相关肽(CGRP)在滑膜中的表达.结果 与假手术组比较,模型组大鼠疼痛阈值降低(P<0.01),足爪平均强度和最大接触面积减少(P<0.01);与PB21、Dex单独给药组比较,PB21+Dex组疼痛阈值降低时间延迟;PB21+Dex组直至48 h仍可升高足爪平均强度和最大接触面积值,且与PB21、Dex单独给药比较差异有统计学意义(P<0.05).检测滑膜组织GAP43和CGRP结果显示,PB21、Dex单独给药可降低4、24 h这两个时间点的蛋白表达水平,PB21+Dex组48 h仍可显著降低GAP43和CGRP表达水平,且与PB21、Dex单独给药组比较差异有统计学意义(P<0.05).结论 低剂量Dex可以延长PB21对KOA大鼠的镇痛作用,其作用可能与降低疼痛相关蛋白CGRP、GAP43的表达有关.

Objective To examine the impact and partial mechanism of bupivacaine sustained-release drug(code PB21)in combination with low-dose dexamethasone(Dex)on the analgesic time of rats with knee osteoarthritis(KOA).Methods Using the techniques of anterior cruciate ligament transection and meniscus instability,a rat KOA model was created.After eight weeks,SD mice were split into three groups at random:a group for the model,one for Dex(50 μg),one for PB21(1.5 mg),and one for combined administration(1.5 mg PB21/50 μg Dex),with a control group that received a sham operation.The pain thresholds of KOA rats were measured using a Pres-sure Application Measurement(PAM)at different intervals before to delivery and 4,24,36,and 48 hours following administration;to gauge changes in discomfort,a CatWalk was used to assess the rats'average foot strength and maximum contact area before,four,twenty-four,and forty-eight hours after treatment.A portion of the rats were put to sleep at four,twenty-four,and forty-eight hours following the injection,and the joint synovium was removed for paraffin sectioning.Immunohistochemistry was used to identify the expression of GAP43 in the synovium,whereas immunofluorescence was used to identify the expression of CGRP in the same tissue.Results The average strength and maximum contact area of the foot and claw decreased(P<0.01),and the pain threshold decreased(P<0.01)in the model group compared to the sham operation group.The PB21+Dex group experienced a delayed pain threshold lowering time delay when compared to the PB21 and Dex treatment groups alone.Up to 48 hours lat-er,the combination administration group's average strength and maximum contact area of the foot paw remained ele-vated,and there was a statistically significant difference(P<0.05)between the combined administration group and PB21 and Dex alone.GAP43 and CGRP expression levels in synovial tissue were detected.The results indica-ted that PB21 and Dex alone could lower protein expression levels at 4 and 24 h at the two time points,and that the PB21+Dex group could still significantly lower GAP43 and CGRP expression levels at 48 h.At the 48 h time point,the PB21+Dex group was statistically significant when compared to the PB21 and Dex alone administration group(P<0.05).Conclusion In summary low dose dexamethasone can prolong the analgesic effect of PB21 on KOA rats,which is connected to reducing the expression of pain related proteins CGRP and GAP43.

储柱平;杜天玺;谢琼霞;王旭蕾;王惠敏;鲁晓蓉;严尚学

安徽医科大学临床药理研究所,合肥 230032安徽医科大学实验动物中心,合肥 230032创新药物成药性评价安徽省重点实验室,合肥 230032安徽医科大学临床药理研究所,合肥 230032||安徽医科大学实验动物中心,合肥 230032

药学

地塞米松PB21骨关节炎疼痛

dexamethasonePB21osteoarthritispain

《安徽医科大学学报》 2024 (007)

1225-1230 / 6

安徽省高校自然科学研究项目(编号:KJ2020ZD15)

10.19405/j.cnki.issn1000-1492.2024.07.018

评论